2011年至2013年医院头孢菌素类抗菌药物应用分析  

Analysis on Clinical Application of Cephalosrins in Our Hospital during 2011-2013

作　　者：赵大贵[1] 张磊[1] 汪明群[1] 

机构地区：[1]四川省宜宾市第一人民医院药剂科,四川宜宾644000

出　　处：《中国药业》2015年第13期52-54,共3页China Pharmaceuticals

摘　　要：目的分析头孢菌素类抗菌药物的临床应用情况,为临床合理应用提供参考。方法采用药物限定日剂量(DDD)分析方法,对医院2011年至2013年头孢菌素类药物的品种、用药金额、用药频度(DDDs)及限定日费用(DDC)等数据进行统计和分析。结果头孢菌素类抗菌药物的用药金额、DDDs和DDC均呈逐年上升趋势,其中第3代头孢菌素类药物占临床治疗的主导地位。结论第3代头孢菌素药物使用明显增加,为减少细菌耐药性的发生,应采取措施防止滥用该类药物。Objective To analyze the clinical application situation of cephalosporins in our hospital to provide reference for their rational use in clinic. Methods The defined daily dose （DDD） analysis method was adopted to conduct the statistical analysis on the data of the varieties, consumption sum, DDDs and DDC, etc. of cephalosporlns in our hospital during 2011-2013. Results The consumption sum, DDDs and DDC of cephalosporins showed the upward trend year by year, in which the third generation cephalosporins occupied a dominant place in clinical treatment. Conclusion The consumption sum of the third generation cepnalosporin has increased sharply. The measures should be adopted to prevent the abuse of cephalosporins for reducing the occurrence of bacterial drug resistance.

关 键 词：头孢菌素 用药金额 用药频度 限定日费用 

分 类 号：R969.3[医药卫生—药理学] R978.1[医药卫生—药学]